Filing Details
- Accession Number:
- 0001225208-10-008972
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-29 13:00:00
- Reporting Period:
- 2010-03-25
- Filing Date:
- 2010-03-29
- Accepted Time:
- 2010-03-29 14:11:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1275654 | P David King | 531 South Spring Street Burlington NC 27215 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-25 | 30,000 | $39.00 | 123,424 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-25 | 1,372 | $75.00 | 122,052 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-25 | 2,500 | $74.16 | 119,552 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-25 | 30,000 | $74.05 | 89,552 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2010-03-25 | 30,000 | $39.00 | 30,000 | $39.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2005-02-17 | 2014-02-17 | No | 4 | M | Direct |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- Amount shown reflects a 2-for-1 stock split effective on May 10, 2002.
- The price of $74.053 per share represents a weighted average of sales prices ranging from $73.81 to $74.24 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Common stock purchase option granted under the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan.
- The option vests in three equal annual installments beginning on the date reflected in this column.
Billionaire Hedge Funds
